Subscribe Us

header ads

Recents

header ads

Precision Medicine Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - November 01, 2022

 According to the research report, the global precisionmedicine market size is expected to touch USD 175.64 Billion by 2030, from USD 66.1 Billion in 2021, growing with a significant CAGR of 11.5% from 2022 to 2030. 

    Precision Medicine Market Size 2020 to 2030

The precision medicine market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global precision medicine market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global precision medicine market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global precision medicine market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1085

 Report Scope of the Precision Medicine Market

Report CoverageDetails
Market SizeUSD 175.64 Billion by 2030
Growth RateCAGR of 11.5% from 2022 to 2030
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2021
Forecast Period2022 to 2030
Segments CoveredTechnology, Application, End User, Sequencing Technology, Product, Route of Administration, Drugs, Region

This study covers a detailed segmentation of the global precision medicine market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global precision medicine market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical

Market Segmentation

 By Technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Gene Sequencing
  • Companion Diagnostics
  • Others

By Application

  • CNS
  • Immunology
  • Oncology
  • Respiratory
  • Others

By End-Use

  • Diagnostic Companies
  • Pharmaceutical Companies
  • Healthcare IT companies
  • Others

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Research Methodology

The research methodology adopted by analysts for compiling the global precision medicine market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global precision medicine market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Precision Medicine Market, By Technology

7.1. Precision Medicine Market, by Technology Type, 2021-2030
7.1.1. Bioinformatics
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Big Data Analytics
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Drug Discovery
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Gene Sequencing
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Companion Diagnostics
7.1.5.1. Market Revenue and Forecast (2019-2030)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Precision Medicine Market, By Application

8.1. Precision Medicine Market, by Application, 2021-2030
8.1.1. CNS
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Immunology
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Oncology
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Respiratory
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Precision Medicine Market, By End-Use

9.1. Precision Medicine Market, by End-Use, 2021-2030
9.1.1. Diagnostic Companies
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Healthcare IT companies
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Precision Medicine Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by End-Use (2019-2030)

Chapter 11. Company Profiles

11.1. Biocrates Life Sciences
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Tepnel Pharma Services
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Novartis
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Qiagen
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Quest Diagnostics
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Menarini Silicon Biosystems
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. NanoString Technologies
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eagle Genomics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Pfizer
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Intomics
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Roche
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Teva Pharmaceutical
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Tags:

Post a Comment

0 Comments